Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
In accordance with the principle of “PICOS,” it was defined as following: (1) P: the children with SDNS or FRNS; (2) I: treated with MMF or other immunosuppressants (TAC, CsA, and levamisole; (3) C: MMF vs. other immunosuppressants (TAC, CsA, and levamisole); (4) O: relapse-free survival rate within 1 year, the number of relapses within 1 year, cumulative prednisone dosage, and incidence of adverse reactions; (5) S: a meta-analysis of RCTs and a prospective cohort study.
Copyright and License information: ©2021 Xiang, Qiu and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
